BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 19, 2026

Regulatory

  • Regulatory
    • 505(b)(2)
    • 510(k)
    • Accelerated review
    • ANVISA
    • BARDA
    • BLA
    • Breakthrough therapy
    • BsUFA
    • CDRH
    • Central Drugs Standard Control Organization
    • Centre for Pharmaceutical Administration Health Sciences Authority
    • CHMP
    • Class I
    • Class II
    • Class III
    • CMS
    • Courts
    • Danish Medicines Agency
    • De novo
    • EMA
    • Fast track
    • FDA
    • FTC
    • GDUFA
    • GMP
    • Health Canada
    • ICH
    • IDE
    • IND
    • Irish Medicines Board
    • Italian Pharmaceutical Agency
    • Legislation
    • MDUFA
    • Medical Countermeasures
    • Medical Products Agency
    • Medicare
    • Medicines Control Council
    • Medicines Evaluation Board
    • Medsafe - Medicines and Medical Devices Safety Authority
    • MHRA
    • Ministry of Health
    • MHLW
    • MOHW
    • NDA
    • NICE
    • NIH
    • NME
    • NMPA
    • Orange book
    • Orphan drug
    • Patents
    • PDUFA
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • PMA
    • PMDA
    • Policy
    • Priority review
    • Product recall
    • Qualified infectious disease product
    • SEC
    • TGA
    • Trade
    • WHO
Home » Topics » Regulatory
  • May 19, 2026

    SEC looks to reforms to Make IPOs Great Again

    In a move aimed at incentivizing companies to go and stay public, the U.S. SEC proposed two rulemakings May 19 as a foundation to the agency’s Make IPOs Great Again agenda.
  • China and us flags
    May 19, 2026
    By Mari Serebrov

    Life sciences ‘sweet’ opportunity in US-China talks

    Of all the issues that could be on the table at the talks between U.S. President Donald Trump and China President Xi Jinping, the life sciences sector is the “sweet spot” for collaboration between the two countries in a way that would benefit the world, Sen. Thom Tillis, R-N.C., said in a Brookings Institution webinar in advance of the two-day summit that starts May 14.
  • May 19, 2026
    By Mari Serebrov

    Supreme Court upholds FCA’s ‘whistle while you work’

    Eli Lilly and Co. lost its bid to have the U.S. Supreme Court strike down the whistleblower provisions in the False Claims Act (FCA) as unconstitutional.
Read More

Blog Posts

  • Aug. 11, 2016
    By Mari Serebrov

    Will biosimilar carve-outs put R&D for older MAbs on ice?

  • Feb. 27, 2013
    By Mari Serebrov

    Omontys Recall Rings Alarm Over Biosimilars

  • Jan. 29, 2013
    By Mari Serebrov

    Don’t Call Them Generics!

Read More

Authors

  • Mari Serebrov
  • Jihyun Kim
  • Tamra Sami
  • Randy Osborne
  • Brian Orelli
  • Katie Pfaff
More Authors

Pages

  • Regulatory data of biopharma companies in 2026
  • /CEO_tariff_comments
  • /Trump_administration_executive_orders
  • /indirect_costs_of_NIH_grants
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing